Comparison between free serum thyroxine levels, measured by analog and dialysis methods, in the presence of perfluorooctane sulfonate and perfluorooctanoate

Reproductive Toxicology

Volumn 33, Issue 4, 2012, Pages 552-555

  Lopez Espinosa, Maria Jose ^a   Fitz Simon, Nicola ^a   Bloom, Michael S ^b   Calafat, Antonia M ^c   Fletcher, Tony ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Free thyroxine; FT4; Perfluorooctane sulfonate; Perfluorooctanoate; PFOA; PFOS; Thyroid hormones

Indexed keywords

PERFLUOROOCTANE; PERFLUOROOCTANESULFONIC ACID; THYROID HORMONE; THYROXINE;

ADULT; ANALOG METHOD; ANALYTIC METHOD; ARTICLE; BINDING ASSAY; BINDING SITE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIALYSIS METHOD; ELECTROCHEMILUMINESCENCE IMMUNOASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE BINDING; HUMAN; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROMETRY DETECTION AFTER EQUILIBRIUM DIALYSIS; MALE; MASS SPECTROMETRY; PROTEIN BINDING; PROTEIN INTERACTION; SPECIES DIFFERENCE; THYROXINE BLOOD LEVEL;

ADULT; ALKANESULFONIC ACIDS; CHEMISTRY TECHNIQUES, ANALYTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; DIALYSIS; ELECTROCHEMICAL TECHNIQUES; FEMALE; FLUOROCARBONS; HUMANS; LIMIT OF DETECTION; LUMINESCENT MEASUREMENTS; MALE; OCTANOIC ACIDS; REGRESSION ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; THYROXINE; WATER POLLUTANTS, CHEMICAL;

ANIMALIA;

EID: 84861528948     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2011.04.002     Document Type: Article

References (23)

1. Lau C., Thibodeaux J.R., Hanson R.G., Rogers J.M., Grey B.E., Stanton M.E., et al. Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation. Toxicol Sci 2003, 74:382-392.
2. Luebker D.J., York R.G., Hansen K.J., Moore J.A., Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters. Toxicology 2005, 215:149-169.
3. Seacat A.M., Thomford P.J., Hansen K.J., Clemen L.A., Eldridge S.R., Elcombe C.R., et al. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 2003, 183:117-131.
4. Chang S.C., Thibodeaux J.R., Eastvold M.L., Ehresman D.J., Bjork J.A., Froehlich J.W., et al. Negative bias from analog methods used in the analysis of free thyroxine in rat serum containing perfluorooctanesulfonate (PFOS). Toxicology 2007, 234:21-33.
5. Butenhoff J., Costa G., Elcombe C., Farrar D., Hansen K., Iwai H., et al. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol Sci 2002, 69:244-257.
6. Fuentes S., Colomina M.T., Rodriguez J., Vicens P., Domingo J.L. Interactions in developmental toxicology: concurrent exposure to perfluorooctane sulfonate (PFOS) and stress in pregnant mice. Toxicol Lett 2006, 164:81-89.
7. Steenland K., Fletcher T., Savitz D.A. Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA). Environ Health Perspect 2010, 118:1100-1108.
8. Bloom M.S., Kannan K., Spliethoff H.M., Tao L., Aldous K.M., Vena J.E. Exploratory assessment of perfluorinated compounds and human thyroid function. Physiol Behav 2010, 99:240-245.
9. Dallaire R., Dewailly E., Pereg D., Dery S., Ayotte P. Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults. Environ Health Perspect 2009, 117:1380-1386.
10. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 2003, 45:260-270.
11. Olsen G.W., Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int Arch Occup Environ Health 2007, 81:231-246.
12. Emmett E.A., Shofer F.S., Zhang H., Freeman D., Desai C., Shaw L.M. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 2006, 48:759-770.
13. Inoue K., Okada F., Ito R., Kato S., Sasaki S., Nakajima S., et al. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy. Environ Health Perspect 2004, 112:1204-1207.
14. Frisbee S.J., Brooks A.P., Maher A., Flensborg P., Arnold S., Fletcher T., et al. The C8 health project: design, methods, and participants. Environ Health Perspect 2009, 117:1873-1882.
15. Kato K., Basden B.J., Needham L.L., Calafat A.M. Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals. J Chromatogr A 2011, 1218:2133.
16. Caudill S.P., Schleicher R.L., Pirkle J.L. Multi-rule quality control for the age-related eye disease study. Stat Med 2008, 27:4094-4106.
17. Centers for Disease Control and Prevention (CDC). Fourth National Report on Human Exposure to Environmental Chemicals-Updated Tables. February. 2011. http://www.cdc.gov/exposurereport/data_tables/chemical_group_11.html.
18. Larsson M., Pettersson T., Carlstrom A. Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. Gen Comp Endocrinol 1985, 58:360-375.
19. Benvenga S., Lapa D., Trimarchi F. Thyroxine binding to members and non-members of the serine protease inhibitor family. J Endocrinol Invest 2002, 25:32-38.
20. Han X., Snow T.A., Kemper R.A., Jepson G.W. Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem Res Toxicol 2003, 16:775-781.
21. Jones P.D., Hu W., De Coen W., Newsted J.L., Giesy J.P. Binding of perfluorinated fatty acids to serum proteins. Environ Toxicol Chem 2003, 22:2639-2649.
22. Weiss J.M., Andersson P.L., Lamoree M.H., Leonards P.E., van Leeuwen S.P., Hamers T. Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol Sci 2009, 109:206-216.
23. Wang R., Nelson J.C., Weiss R.M., Wilcox R.B. Accuracy of free thyroxine measurements across natural ranges of thyroxine binding to serum proteins. Thyroid 2000, 10:31-39.